Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports

Myelodysplastic syndromes are heterogeneous disorders. Patients with myelodysplastic syndrome disease often have ineffective hematopoiesis, cytopenias, blood cell dysplasia in one or more cell types, and are a...

http://ift.tt/2pZa1Dr